Tocilizumab (Actemra)

From HemOnc.org - A Hematology Oncology Wiki

Jump to navigation Jump to search

Mechanism of action

Monoclonal antibody directed against the IL-6 receptor

Diseases for which it is used

Castleman disease

History of changes in FDA indication

2010-01-08: Initial FDA approval for rheumatoid arthritis

Also known as

Brand name: Actemra

Retrieved from "https://hemonc.org/w/index.php?title=Tocilizumab_(Actemra)&oldid=70519"